509 related articles for article (PubMed ID: 33259650)
21. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
[TBL] [Abstract][Full Text] [Related]
22. Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer.
Matsuo K; Klar M; Khetan VU; Violette CJ; Youssefzadeh AC; Yessaian AA; Roman LD
Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():91-96. PubMed ID: 35763967
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
[TBL] [Abstract][Full Text] [Related]
25. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer.
Holloway RW; Ahmad S; Kendrick JE; Bigsby GE; Brudie LA; Ghurani GB; Stavitzski NM; Gise JL; Ingersoll SB; Pepe JW
Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777
[TBL] [Abstract][Full Text] [Related]
26. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G
Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100
[TBL] [Abstract][Full Text] [Related]
27. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
[TBL] [Abstract][Full Text] [Related]
28. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
[TBL] [Abstract][Full Text] [Related]
29. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
30. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
31. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
[TBL] [Abstract][Full Text] [Related]
32. Comparison of two intraoperative examination methods for the diagnosis of sentinel lymph node metastasis in clinically early stage endometrial cancer: A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-003).
Taşkın S; Varlı B; Altın D; Takmaz Ö; Vatansever D; Ersöz CC; Turan H; Bulutay P; Zeren H; Havare SB; Karabük E; Naki M; Güngör M; Köse F; Ortaç F; Arvas M; Ayhan A; Taşkıran Ç
Eur J Obstet Gynecol Reprod Biol; 2021 Jun; 261():72-77. PubMed ID: 33894621
[TBL] [Abstract][Full Text] [Related]
33. Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer.
Kim YN; Eoh KJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Int J Gynecol Cancer; 2020 Mar; 30(3):318-324. PubMed ID: 31992601
[TBL] [Abstract][Full Text] [Related]
34. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging.
Kim CH; Soslow RA; Park KJ; Barber EL; Khoury-Collado F; Barlin JN; Sonoda Y; Hensley ML; Barakat RR; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Jun; 23(5):964-70. PubMed ID: 23694985
[TBL] [Abstract][Full Text] [Related]
35. Impact of sentinel lymph node mapping on survival in patients with high-risk endometrial cancer in the early stage: A matched cohort study.
Jaafar E; Gaultier V; Wohrer H; Estevez JP; Gonthier C; Koskas M
Int J Gynaecol Obstet; 2024 May; 165(2):677-684. PubMed ID: 38226675
[TBL] [Abstract][Full Text] [Related]
36. A selective anatomically based lymph node sampling can replace a side specific pelvic lymphadenectomy in endometrial cancer with failed sentinel node mapping.
Bollino M; Geppert B; Lönnerfors C; Persson J
Eur J Cancer; 2024 Jun; 204():114049. PubMed ID: 38657525
[TBL] [Abstract][Full Text] [Related]
37. The efficiency of a combined injection technique for sentinel lymph node mapping in intermediate-high-risk endometrial cancer.
Wang Q; Wang B; Wang L; Xue Y; Shan W; Luo X; Wang C; Chen X
J Surg Oncol; 2021 Dec; 124(8):1551-1560. PubMed ID: 34496048
[TBL] [Abstract][Full Text] [Related]
38. Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy.
Bollino M; Geppert B; Lönnerfors C; Falconer H; Salehi S; Persson J
Int J Gynecol Cancer; 2020 Mar; 30(3):339-345. PubMed ID: 32075897
[TBL] [Abstract][Full Text] [Related]
39. One-step nucleic acid amplification vs ultrastaging in the detection of sentinel lymph node metastasis in endometrial cancer patients.
Kosťun J; Pešta M; Sláma J; Slunéčko R; Vlasák P; Bouda J; Novotný Z; Topolčan O; Kučera R; Kulda V; Houfková K; Berezovskiy D; Bartáková A; Presl J
J Surg Oncol; 2019 Mar; 119(3):361-369. PubMed ID: 30508294
[TBL] [Abstract][Full Text] [Related]
40. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.
Buda A; Restaino S; Di Martino G; De Ponti E; Monterossi G; Dinoi G; Magni S; Quagliozzi L; Dell'Orto F; Ciccarone F; Lamanna M; Scambia G; Landoni F; Fanfani F
Eur J Surg Oncol; 2018 Oct; 44(10):1562-1567. PubMed ID: 30077521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
